Parker-Hannifin

Parker-Hannifin Reports Record Q2 Earnings with 6.6% Organic Growth and 150 bps Margin Expansion

Stifel Boosts Parker Hannifin's Price Target to $965, Maintains Hold Rating

Wells Fargo Raises Parker Hannifin Price Target to $1050, Maintains 'Overweight' Rating

JP Morgan Raises Parker Hannifin's Price Target to $1100, Maintains 'Overweight' Rating

Stifel Boosts Parker-Hannifin's Price Target to $941, Maintains Hold Rating

Catalyst<ul> <li>Most analysts rate PH Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a volatile state and the direction is not clear enough.</li> <li>Bearish signals are obviously dominant (3 bearish vs 1 bullish).</li> <li>Fund flows show negative trends for medium large and extra-large order sizes indicating lack of institutional confidence.</li></ul>

Key Factors

Parker-Hannifin reports record Q2 sales of $5.2 billion with 6.6% organic growth and 150 bps of margin expansion.Parker-Hannifin raises full-year 2026 adjusted EPS guidance to $30.70, citing strong aerospace performance and the Filtration Group acquisition.Parker-Hannifin acquires Filtration Group Corporation to expand its market presence and industrial capabilities.Several analysts raise Parker-Hannifin's price target, with Wells Fargo, JP Morgan, and Citigroup setting new targets between $1050 and $1100.Sterling Investment Counsel increases its stake in Parker-Hannifin by 24.38% to 1,546 shares, valued at $1,329,230.

PH News